🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

PSVD is a relatively new term, but this disease complex has been recognized for decades. Here is everything you need to know 💡David Kleiner CKoh

So impressive!

🚨 Just released! The 2025 ACG Clinical Guideline on Crohn’s Disease in Adults. ⁦ let’s dive into advanced diagnostic strategies & risk profiling. 👇 ⁦ACG⁩ journals.lww.com/ajg/fulltext/2…

Apply now for the 2025–2026 Women’s Leadership Development Program to build your skills, grow your network, and connect with a senior mentor. Submit your application by July 30! bit.ly/3ZMFozW #WomenInMedicine #Hepatology

🚨 Not to Miss Free CME Event! 🚨 June 11 – LIVE from Cleveland Clinic: MASLD - NEW THERAPEUTIC OPPS. Join Sobia Laique MD Michelle Kim Ali Aminian Cleveland Clinic MD, Keren Zhou, Yael Mauer, Mazhar Khalil for this CME MOC virtual event. Register now: bit.ly/LIVECC2025

🚨 New ACG Crohn’s Guidelines (2025) ▪️Scope at 6–12 mo post-op ▪️Early advanced therapy = key ▪️Anti-TNF, IL-23, JAKi > mesalamine ▪️High-risk = smoking, prior surgery, penetrating dz ▪️Surgery for abscess >2cm or strictures 🔗 bit.ly/acg-crohns-2025

.OpenEvidence, a leading medical information #AI-powered platform for health care professionals, has signed a multi-year content agreement with the JAMA Network. Learn more: ja.ma/4jvqwNn

Impact of Early Albumin Use for Resuscitation in Patients With Septic Shock and Cirrhosis Kianoush Kashani #MayoClinicKidney onlinelibrary.wiley.com/doi/10.1155/cj…

Yesterday, AASLD applauded Senate leaders for championing the Cure Hepatitis C Act of 2025. Today, we‘re asking our hepatology community to take action—use our new Policy Action Center to contact your senators and show your support. Act now: bit.ly/4jADfi5

🦠 Why prescribe antibiotics for SBP prophylaxis? Why *not*? ⚖️ Weigh the benefits of prevention vs the risks of resistance 📉 Can we reduce mortality without fueling antimicrobial harm? 🔍 Dive into the evidence behind a high-stakes clinical dilemma in our AASLD

Our new paper on Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with MASH: a randomised, phase 2a trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa… Manuel Romero-Gómez Daniel Huang Naim Alkhouri Mazen Noureddin, MD, MHSc Quentin M. Anstee Christopher A. Longhurst, MD

🚨 Bariatric surgery cuts macrovascular risk & mortality in MASLD + T2DM + obesity. CAD ↓69%, stroke ↓62%, mortality ↓70%! #LiverTwitter #MedTwitter Sociedad Española de Patología Digestiva (SEPD) Asociación Española para el Estudio del Hígado dmsjournal.biomedcentral.com/articles/10.11…

A new #EASLQuiz in collaboration with ESPGHAN is out! Test your knowledge on congenital portosystemic shunt with this interesting case of a 23 year old male patient. 🎮: easlcampus.eu/quiz/question/… #LiverTwitter #LiverX

Head-to-Head Trials in IBD by Dr Beatrice Gros

🇨🇦 in #eahpba2025 champions league 🏆 HELIX RCT of TXA vs placebo for hepatectomy by Paul Karanicolas No change in 🩸transfusion but ⬆️ morbidity with TXA ⚠️ don’t use TXA for hepatectomy See 📝 JAMA 👉🏻 jamanetwork.com/journals/jama/…

Surprised this wasn’t already the norm in the UK.

Beautiful.

Hepatic encephalopathy is horrible It can present as disorientation and coma. But often causes poor quality of life, falls, and other trauma We want to prevent it. How can we predict it?